TCIIS
ONC

TIAA-CREF Individual & Institutional Services’s BeOne Medicines Ltd ONC Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
4,285
-154
-3% -$45.4K ﹤0.01% 329
2026
Q1 		$1.32M Buy
+4,439
New +$1.44M 0.01% 298

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's ONC Position: Q2 2026 in Review

TIAA-CREF Individual & Institutional Services reduced its BeOne Medicines Ltd (ONC) stake by 3.5% in Q2 2026, selling an estimated $45.4K and leaving 4,285 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #329.

TIAA-CREF Individual & Institutional Services first reported a position in ONC in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.32M in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • TIAA-CREF Individual & Institutional Services held 4,285 shares of BeOne Medicines Ltd worth $1.22M as of Q2 2026.
  • TIAA-CREF Individual & Institutional Services sold 154 BeOne Medicines Ltd shares in Q2 2026, an estimated $45.4K.
  • BeOne Medicines Ltd made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q2 2026, its #329 holding.
  • TIAA-CREF Individual & Institutional Services first reported a position in BeOne Medicines Ltd in Q1 2026 and has held it in 2 quarters since.
  • TIAA-CREF Individual & Institutional Services's BeOne Medicines Ltd position peaked at $1.32M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q2 2026, filed 10 Aug 2026.